Introduction: Giant cell arteritis is a vasculitis which predominantly affects the carotid artery and its extra-cranial branches. Its classical presentation is that of headache with scalp tenderness but should be considered in anyone over the age of fifty years with transient visual symptoms, unexplained facial pain and/or jaw claudication. As a systemic vasculitis, clinical signs may vary, however respiratory complications compared to other vasculitides are uncommon. We presenta case of newonset pleural effusion as apresenting featureof giant cell arteritis. Case description: A seventy-year-old man previously fit and well was referred to respiratory clinic after a CXR done for ongoing non-productive dry cough showed a small right sided pleural effusion. Accompanying symptoms included a reduced appetite with around 6kg weight loss over the preceding month. His past medical history included a TIA, occasional palpitations and prostatectomy for a benign prostatic hypertrophy. His only regular medication was aspirin. He never smoked and was a retired communications engineer with no known history of asbestos exposure. On examination he had no peripheral stigmata of respiratory disease and chest auscultation was clear. He had routine blood tests which revealed a normocytic anaemia (Hb 108), an elevated CRP (145.6) and elevated ESR (131).LFTs were mildly deranged and U&Es were unremarkable. A subsequent CT scan was arranged which confirmed a small right sided pleural effusion and a small pericardial effusion. General soft tissue oedema surrounding the upper abdominal organs was also noted. There was no evidence of malignancy. For workup of anaemia, he underwent a gastroscopy and colonoscopy. Gastroscopy was normal and colonoscopy revealed a single pedunculated sigmoid polyp which histologically was an adenoma. An echocardiogram showed no evidence of heart failure. 24 hour ECG telemetry was arrangeddue to palpitations but this was essentially normal. The patient eventually developed a bilateral temporal headache and malaise. He was commenced on 40mg prednisolone. While awaiting temporal artery biopsy he subsequently developed jaw claudication and prednisolone was increased to 60mg a day. Biopsy confirmed giant cell arteritis. All his symptoms improved with steroids including fatigue, headaches, cough and he started to regain weight. Similarly biochemically all abnormalities normalised. A subsequent CXR showed complete resolution of the pleural effusion. Discussion: Giant cell arteritis (GCA), like all systemic vasculitides, has been recognised to often involve the respiratory system. This has been reported to be in as high as 31% of patients with GCA. Notably, a persistent dry cough associated with fever has been recognised to be the most common respiratory symptom and has also been found to be one of the more atypical initial manifestations of GCA. This correlates with raised inflammatory markers and both of which were seen in the subject of this report. Although presence of a cough does not appear to correlate with other clinical symptoms of this particular vasculitis, it has been shown to markedly improve in response to steroids, suggesting its aetiology is GCA driven. The presence of pleural effusion however is far less common and indeed is exceptionally rare to be part of the initial presentation of GCA. Thereare ahandfulof cases in the literature, and most often the finding of pleural effusion coexists with more typical signs of GCA. The pleural effusion in our case was relatively small and was not considered safe for diagnostic aspiration. Rapid and complete resolution of an otherwise persistent pleural effusion with commencement of prednisolone points to GCA as the primary cause of the pleural effusion. Key learning points: This case shows that GCA can rarely present as cough and pleural effusion which may precede more typical clinical features often associated with GCA. The importance of recognition of GCA as the cause of pulmonary manifestations in such cases is that appropriate steroid therapy can induce complete resolution and avoid the need for further, potentially harmful invasive investigations. Our case further highlights the complexity of large vessel vasculitis such as GCA due to their varied presentation and symptoms. In patients with an unexplained weight loss, aside from malignancy the differential diagnoses shouldinclude vasculitis. Conflicts of interest: The authors have declared no conflicts of interest.
GIANT CELL ARTERITIS AND TAKAYASU ARTERITIS: TWO SIDES OF THE SAME COIN IN AN ELDERLY FEMALE?
Hira Ghuman 1,2 and Muditha Samaranayaka 1 1 Rheumatology, Salford Royal NHS Foundation Trust, Manchester, United Kingdom, and 2 Department of Rheumatology, University of Manchester, Manchester, United Kingdom Introduction: Large vessel vasculitis (LVV) is a heterogeneous group of conditions, comprising of giant cell arteritis (GCA) and Takayasu arteritis (TAK). The American College of Rheumatologists (ACR) criteria provides a scoring system based on age, symptoms, and clinical examination findings, investigations to reach a diagnosis of either GCA or TAK. Similarly, European League Against Rheumatism (EULAR) recommendations discuss various imaging modalities in visualising vascular inflammation. Management is typically glucocorticoids, but for relapsing disease the challenge is finding suitable glucocorticoid-sparing agents. Here we describe a case of LVV presenting with great diagnostic complexity, discussing diagnostic modalities, treatment options and complications of therapy. Case description: A 64-year-old female was referred to rheumatology clinic following extensive negative investigations, apart from on-going inflammatory response under gastroenterology for unexplained weight loss forover ayear. Further history revealed lower limb cramps, fatigue and frontal headaches. She did not report any jaw claudication or visual disturbances but had atypical neck pain. As the main carer for her mother with dementia all these symptoms led to significant functional impairment and a great deal of anxietyforthe patient. Under the gastroenterologists, she has had negative upper and lower GI endoscopies, CT thorax, abdomen and pelvis, labelled white cell scan and isotope bone scan in addition to a comprehensive septic screen including spinal imaging. A diagnosis of systemic vasculitis was suspected. ANCA screen was negative. Patient declined a superficial temporal artery biopsy. A FDG PET scanconfirmed increased activityinmediumand large sizedvessels, such as the common carotids, descending thoracic aorta, vertebral arteries, andfemoral arteries.Sitesof metabolic hypersignalwere consistent with large vessel vasculitis. Previous CT angiography was reviewed once again. No evidence of TAK was identified. GCA-LVV was decided as the most likely diagnosis. The patient responded well to induction oral steroids with marked andrapidimprovementintheinflammatoryresponse.Duringtheweaning down of steroids, the weight loss and the inflammatory response recurred. Steroid sparing therapy was added on. Azathioprine was shortly discontinued owing to deranged liver function tests despite normal TPMT levels. Methotrexate was stopped as it caused suspected acute pneumonitis. Oral bisphosphonates were not tolerated and she was listed for IV. Shortly after, she suffered a low trauma fracture neck of femur which caused fat emboli leading to a dense stroke. She recovered gradually with anticoagulation. Currently she is being screened for SC tocilizumab. Discussion: Diagnosing LVV can be challenging owing to non-specific symptoms at presentation. Although our patient's presentation of fatigue, weight loss and worsening inflammatory markers were reflective of a vasculitis-like pathology from the onset, confirming the exact diagnosis was far from straightforward. LVV has countless clinical manifestations with new onset headaches being the most predominant. Limb claudication, another presenting symptom, is described in literature as a clinical manifestation of LVV in 5-15% of cases. The patient's complaint of neck pain is also a feature associated with external carotid artery disease. Various imaging modalities, including MRI, CT angiogram, and FDG PET scans have been implicated in the diagnosis of LVV. Currently, no i42 27 September 2019 POSTER PRESENTATIONS diagnostic threshold exists beyond which uptake is defining of vasculitis. One study (n ¼ 40) evaluating diagnostic accuracy of PET scans in LVV cases against control patients, calculated 80% specificity and 65% sensitivity. Whereas, another study (n ¼ 24) reported 100% specificity in use of PET scansfordiagnosis of extracranial GCA.
A second dilemma encountered in this case following LVV diagnosis, was concluding the subtype. The patient's diminishing pulses, a characteristic feature of TAK, was evaluated using angiography techniques. Results were inconsistent with the expected characteristic aortic stenosis or occlusions described by TAK diagnostic criteria. Despite no histological assessment from superficial temporal arteries, due to lack of scalp tenderness and jaw claudication, diagnosis was confirmed and managed as GCA-LVV. This case was further complicated by finding a management regime both effective at tackling GCA-LVV activity, but also suitable for the patient. Disease which follows a relapsing course is indication for glucocorticoid-sparing agents. Published data is increasingly favouring use of tocilizumab, with a randomised control trial (n ¼ 251) showing sustained remission in around 56% of patients. The aim with our patient remains finding a balance between adverse side effects and medicationefficacy. Key learning points: LVV is frequently the least obvious diagnosis, but nonetheless an important differential in a rheumatology clinic. The journey to diagnosing LVV is convoluted, either taking the route of temporal artery biopsy or various radiological imaging to gain an answer. This case highlights the broad extent of clinical manifestations of LVV, such as limb claudication.
In atypical presentations, with limited feasibility for histological studies, radiological imaging of arterial morphology has proven pivotal in reaching a diagnosis of LVV. A key finding for GCA on ultrasound is the 'halo' sign'. The role of MRI has been evaluated in identifying changes in arterial wall thickness and enhancement of only temporal and occipital arteries. CT angiogram can demonstrate signs of active vessel disease more centrally. PET scans, although utilise ionising radiation, image the aorta and its branches in detail-therefore, guiding diagnosis. This case would benefit the audience by demonstrating the diagnostic and treatment dilemmas in LVV. It will also highlight the disease burden of vasculitis especially due to the rare adverse effects this patient suffered due medication. The conference would be a platform for the authors to learn from the experiences of various clinicians, around the diagnosis of LVV and to share with the department. We would very much like to have feedback from the experts in the field and also learn more about advances in biomarkers, like interleukins, now linked to LVV.
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The authors have declared no conflicts of interest. Introduction: Behc¸et's Disease (BD) is a complex, multisystem autoinflammatory disorder. The most frequent manifestations are oral aphthous ulcers, genital ulcers and uveitis. Vascular involvement is less common but one of the major causes of mortality and morbidity.This case highlights the need to consider BD, especially in young, male, patients with arterialabnormalitiesand the challenges of treatment.
VASCULAR BEHC¸ET'S DISEASE IN
Case description: A 20-year-old man with a Moroccan father, presented to A&E with abdominal pain, constipation and night sweats, following recurrent admissions with lower abdominal and back pain. On this occasion he was noted to have a CRP of 160 mg/L and a subsequent CT scan of the abdomen showed a 4 cm pseudo-aneurysm arising from the right lateral infrarenal abdominal aorta which was initially repaired with open surgery and a vein graft. This subsequently leaked and so he had further surgery and anEVAR procedure. On further questioning it was noted that he had had frequent mouth ulcers for seven years and also episodes of epididymo-orchitis and folliculitis and the possibility of BD was considered. He was seen in the Birmingham Behc¸et's Centre of Excellence and started azathioprine together with oral prednisolone. Six months later he required embolization of a left renal artery pseudoaneurysm and stent-grafting of the same artery. Given these new changes he was commencedon IV cyclophosphamide. Despite six pulses of cyclophosphamide and high doses of prednisolone he continued to have a raised CRP and so was switched to tocilizumab infusions. His inflammatory markers initially improved, but after about two years he attended for an infusion and complained of worsening abdominal pain. At that point it was noted that his inflammatory markers had been intermittently raised over the preceding few months. There had been afew breaksin treatment dueto possible infections and non-attendance. A further CT scan was performed that showed disease progression at the distal site of the graft with small new aneurysms. After an MDT discussion it was decided to switch him to infliximab. He has now been on infliximab for over six months and his inflammatory markers have, reassuringly, remained low. Discussion: Arterial involvement in BD is relatively uncommon, presenting variably with stenosis, thrombotic occlusions and aneurysms, as the vasculitic process can affect perivascular and endovascular tissues.
Aneurysms are typically seen a number of years after the initial diagnosis and are believed to be due to an obliterative endarteritis with inflammation causing destruction of elastic and muscle cells in the media. The aneurysms tend to be more saccular, and the abdominal aorta is more frequently involved than the thoracic aorta orpulmonary artery. In this case the initial surgical procedure was performed prior to the diagnosis of BD, so it was not possible to give something such as cyclophosphamide prior to surgical intervention which would be advised. The EULAR guidelines recommend cyclophosphamide and corticosteroids as first line in treatment in arterial involvement. However, no further guidance is given regarding subsequent immunosuppression if needed. In this case the decision to start tocilizumab was made based on successful usein other patients with vascular Behc¸et's disease. Subsequently infliximab was chosen as it has been used more widely in BD including in patients with vascular BD. Biochemically and symptomatically the patient has been well since infliximab was started, but we are currently awaiting a repeat CT scan. This case has also proved challenging as the patient has struggled with the diagnosis and need for frequent hospital appointments. He has had some help from the psychologist available through the Behc¸et's service but has continued to DNA appointments and turn up for infusions at times that suit him. We are hopeful that a longer period of stability will also be beneficial from that point of view. Introduction: Despite being the most common form of primary systemic vasculitis in adults, giant cell arteritis (GCA) remains a difficult diagnosis to make due to the breadth and versatility of presenting symptoms and signs. Many patients present with a myriad of symptoms which don't fit neatly into the American College of Rheumatology criteria (1990) often with a negative or absent temporal artery biopsy. Here we describe an atypical and aggressive presentation of a patient with GCA. Case description: A 77-year old male with a background of pertussis was initially referred to the medical take with 2 weeks of lethargy, raised C-reactive protein (343) and white cell count (27.8) . He admitted to fevers, myalgia and sweats butdenied anyGCA symptoms. Examination revealed no abnormalities. He was treated for an infection of unknown source with broad spectrum antibiotics. A CT chest, abdomen and pelvis showed bibasal consolidation in the lungs with small effusions. He went on to have negative blood, sputum and urine cultures. Despite antibiotic escalations, his inflammatory markers remained high. An echocardiogram showed no vegetations. His pleural effusions were aspirated and revealed atransudative lymphocyticfluid with noacid-fast bacilli. He was then referred to rheumatology. He denied GCA or connective tissue disease symptoms. He had a persistently raised CRP (>150) and WCC (>15) with no fevers. Examination revealed present temporal artery pulses and no abnormalities. Immunology was negative (ANA, ENA, ANCA and CCP). A PET scan showed no changes consistent with a malignancy, large vesselvasculitis orinfection.
